Analyst's Ratings for IMV Inc (IMVIF)

Based on 9 analysts giving stock ratings to IMV Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
33
Buy
56
Hold
11
Sell
0
Strong Sell
0
IMV Inc

IMV Inc. Stock Analysis IMVIF

United States Health Care Nano Cap
IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. The company is headquartered in Dartmouth, Nova Scotia and currently employs 63 full-time employees. The company went IPO on 2018-06-01. The firm has sold all of its assets. The company is not engaged in any business operations.
Read More

IMV Inc (IMVIF) Chart

Financial Metrics & Statements of IMV Inc (IMVIF)

FAQ's for IMV Inc (IMVIF)

  • According to Musaffa’s Shariah screening methodology, IMV Inc (IMVIF) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.